{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:33:43Z","timestamp":1778621623377,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["600375"],"award-info":[{"award-number":["600375"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-031743 \\u2013 PTDC\/BIA-CEL\/31743\/2017"],"award-info":[{"award-number":["POCI-01-0145-FEDER-031743 \\u2013 PTDC\/BIA-CEL\/31743\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-031743"],"award-info":[{"award-number":["POCI-01-0145-FEDER-031743"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BIA-CEL\/31743\/2017"],"award-info":[{"award-number":["PTDC\/BIA-CEL\/31743\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/136046\/2018"],"award-info":[{"award-number":["SFRH\/BD\/136046\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04564\/2020"],"award-info":[{"award-number":["UIDP\/04564\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/112201\/2015"],"award-info":[{"award-number":["SFRH\/BD\/112201\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["CEECIND\/03482\/2018"],"award-info":[{"award-number":["CEECIND\/03482\/2018"]}],"id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["PD\/BD\/105745\/2014"],"award-info":[{"award-number":["PD\/BD\/105745\/2014"]}],"id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-007274"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007274"]}],"id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["ERC-2015-StG-680156-ZPR"],"award-info":[{"award-number":["ERC-2015-StG-680156-ZPR"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000654","name":"Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000654","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jconrel.2021.09.031","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T21:22:53Z","timestamp":1632777773000},"page":"381-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Intratumoral VEGF nanotrapper reduces gliobastoma vascularization and tumor cell mass"],"prefix":"10.1016","volume":"339","author":[{"given":"Fl\u00e1via","family":"Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"Costa-Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio J\u00fanio","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Bessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui D.M.","family":"Travasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Mendes Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.09.031_bb0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0010","series-title":"Cancer Epidemiology. Methods in Molecular Biology","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-60327-492-0_14","article-title":"Epidemiology of brain tumors","author":"Ohgaki","year":"2009"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-016-2269-8","article-title":"Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses","volume":"131","author":"Conroy","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0020","doi-asserted-by":"crossref","first-page":"12081","DOI":"10.1073\/pnas.94.22.12081","article-title":"Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189","volume":"94","author":"Cheng","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2013.11.002","article-title":"Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning","volume":"25","author":"Vempati","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","article-title":"Hypoxia: a key regulator of angiogenesis in cancer","volume":"26","author":"Liao","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0040","series-title":"Systems Biology in Cancer Research and Drug Discovery","first-page":"197","article-title":"Understanding the dynamics of tumor angiogenesis: A systems biology approach","author":"Quinas-Guerra","year":"2012"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0050","series-title":"Vascular Endothelial Growth Factor in Malignant Disease of the Central Nervous System, in Madame Curie Bioscience Database","author":"Stefanik","year":"2000"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1083\/jcb.200906044","article-title":"Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells","volume":"188","author":"Chen","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13311-016-0510-y","article-title":"New directions in anti-angiogenic therapy for glioblastoma","volume":"14","author":"Wang","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0065","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/cbt.5.2.2317","article-title":"A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model","volume":"5","author":"Niola","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0080","doi-asserted-by":"crossref","DOI":"10.3171\/2015.1.FOCUS14743","article-title":"Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals","volume":"38","author":"Wang","year":"2015","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0085","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2147\/OTT.S159913","article-title":"Delivery of bevacizumab by intracranial injection: assessment in glioma model","volume":"11","author":"Liu","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2019.07.033","article-title":"Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles","volume":"309","author":"Sousa","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0095","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1101\/gr.165654.113","article-title":"A mobile insulator system to detect and disrupt cis-regulatory landscapes in vertebrates","volume":"24","author":"Bessa","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0100","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1039\/D0BM00556H","article-title":"Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells","volume":"8","author":"Bai\u00e3o","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0105","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1038\/s41598-017-03959-4","article-title":"A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles","volume":"7","author":"Sousa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.actbio.2018.07.040","article-title":"Nanoparticles provide long-term stability of bevacizumab preserving its antiangiogenic activity","volume":"78","author":"Sousa","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0115","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00285-019-01383-y","article-title":"Simulation of glioblastoma growth using a 3D multispecies tumor model with mass effect","volume":"79","author":"Subramanian","year":"2019","journal-title":"J. Math. Biol."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0120","article-title":"Towards the personalized treatment of Glioblastoma: integrating patient-specific clinical data in a continuous mechanical model","volume":"10","author":"Colombo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D","article-title":"Differential expression of VEGF isoforms in mouse during development and in the adult","volume":"220","author":"Ng","year":"2001","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","article-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","volume":"333","author":"Ferrara","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12918-019-0706-y","article-title":"How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?","volume":"13","author":"Lai","year":"2019","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1593\/neo.07613","article-title":"Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference","volume":"10","author":"Wang","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1189\/jlb.0907632","article-title":"Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma","volume":"84","author":"Koldehoff","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0150","first-page":"4751","article-title":"Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion","volume":"19","author":"Zou","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0155","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3892\/or.2012.1966","article-title":"Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo","volume":"28","author":"Sun","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/0717-6287-47-70","article-title":"Simultaneous silencing of VEGF and KSP by siRNA cocktail inhibits proliferation and induces apoptosis of hepatocellular carcinoma Hep3B cells","volume":"47","author":"Doan","year":"2014","journal-title":"Biol. Res."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0165","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.18632\/oncotarget.6405","article-title":"Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species","volume":"7","author":"Um","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0170","article-title":"A novel zebrafish xenotransplantation model for study of glioma stem cell invasion","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0175","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1038\/s41598-017-14766-2","article-title":"Identify a blood-brain barrier penetrating drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft model","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/53aa27c5-0c32-4904-9278-4a68c39963d2","article-title":"Tumor angiogenesis and vascular patterning: a mathematical model","volume":"6","author":"Travasso","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0185","doi-asserted-by":"crossref","first-page":"8726","DOI":"10.1038\/s41598-018-27034-8","article-title":"Angiogenic factors produced by hypoxic cells are a leading driver of anastomoses in sprouting angiogenesis-a computational study","volume":"8","author":"Moreira-Soares","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0190","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1073\/pnas.0711642105","article-title":"Wound angiogenesis as a function of tissue oxygen tension: a mathematical model","volume":"105","author":"Schugart","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0195","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jtbi.2018.11.018","article-title":"Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs","volume":"462","author":"Lai","year":"2019","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jconrel.2021.09.031_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113165","article-title":"Hypoxia in vascular networks: a complex system approach to unravel the diabetic paradox","volume":"9","author":"Gandica","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.09.031_bb0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12918-017-0446-9","article-title":"Combination therapy for melanoma with BRAF\/MEK inhibitor and immune checkpoint inhibitor: a mathematical model","volume":"11","author":"Lai","year":"2017","journal-title":"BMC Syst. Biol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921005101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921005101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:22:01Z","timestamp":1778300521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921005101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":41,"alternative-id":["S0168365921005101"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.031","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratumoral VEGF nanotrapper reduces gliobastoma vascularization and tumor cell mass","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}